Annovis Bio Inc
ANVS
Get informed when a big investor buys or sells
+ FollowMarket Cap$36.99M
Close$
$0.95
46.9% downside
Current Fair Value
46.9% downsideOvervalued by 46.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $36.99 Million |
|---|---|
| Enterprise Value | $-18,691,958,604.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.4 |
| Beta | 1.19 |
| Outstanding Shares | 27,848,000 |
Return
| Return on Equity | 933.10% |
|---|---|
| Return on Assets | -180.15% |
| Return on Invested Capital | -46.38% |
Valuation & Multiples
| P/E Ratio | -1.09 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 2.57 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.44
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 18, 2026
EPS Estimate
$-0.45
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 58.93% |
|---|---|
| Total Calls | 10,000▼ 96.97% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.85%▼ 14.11% |
|---|---|
| Total Invested | $1.48M▼ 85.98% |
| Investors Holding | 26▼ 36.00% |
ESG Score
No data
About Annovis Bio Inc
CEO: Maria Maccecchini